A. Neuromodulations
■  Attachable Photo Therapeutics Center for e-Healthcare [link]:
Co-investigator, ongoing since 2017, 
supported by the Engineering Research Center of Excellence (ERC) Program supported by National Research Foundation (NRF), Korean Ministry of Science & ICT (MSIT)

B. Cognitive trainings and care programs
■  Development of the Finger-to-Brain Program:
Principal investigator, ‌ongoing since 2015, 
supported by the Korea Institute of Science and Technology

■  Development of the Multimodal Cognitive Enhancement Therapy (MCET) for the patients with mild cognitive impairment and mild dementia:
Principal investigator, completed from 2014 to 2016, 
supported by the Korean Health Industry Development Institute (KHIDI), Ministry of Health and Welfare 
(https://www.ncbi.nlm.nih.gov/pubmed/27802233)

■  Development of a mobile application for patients with mild cognitive impairment and mild dementia using verbal fluency and confrontational naming training: 
Principal investigator, completed from 2014 to 2016, 
supported by the Seoul National University and SK Telecom

■  Efficacy of the cognitive training based on location information and activity in people with mild cognitive impairment:
Principal investigator, completed from 2017 to 2019, 
supported by Institute for Information & communications Technology Promotion (IITP) grant funded by the Korea government (MSIT)

■  Multimodal Intervention study on Dementia Prevention (MISoD):
Principal investigator, ongoing since 2018, 
supported by Ottugi co.

■  Korean version of the Couples Life Story Approach (CLSA-K):
Co-investigator, completed from 2013 to 2015, 
supported by the Korean Health Industry Development Institute (KHIDI), Ministry of Health and Welfare, Republic of Korea
(https://www.ncbi.nlm.nih.gov/pubmed/30470154)

■  Nationwide Survey on Dementia Care in Korea (NaSDECK) [link]:
Principal investigator, completed from 2010 to 2011, 
supported by the research grant from Ministry of Health, Welfare and Family Affairs

‌C. Clinical trials
‌■  Drugs: 
16 clinical trials (5 phase II trials, 9 phase III trials, and 2 phase 4 trials)

‌■  Devices: 
2 clinical trials (2 phase III trials)